GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Judges Scientific
Who Owns Judges Scientific Company?
Understanding company ownership is key to grasping its strategic direction and accountability. Judges Scientific plc, a UK-based group focused on scientific instrument businesses, saw a significant shift with its re-admission to AIM in 2005.
This move solidified its 'buy and build' strategy in a sector recognized for global excellence, particularly within the UK. The company's evolution reflects a deliberate approach to acquiring and nurturing niche scientific instrument businesses.
Judges Scientific plc, established in 2002 and headquartered in London, has grown to encompass approximately 25 businesses as of July 2025. These primarily UK-based entities distribute their products globally to sectors like higher education and scientific research. In the full year ending December 31, 2024, the company reported revenues of £133.6 million, with a market capitalization reaching £398.88 million by August 4, 2025. This growth trajectory highlights the success of its strategic acquisitions and development, including its work with tools like the Judges Scientific BCG Matrix.
Who Founded Judges Scientific?
Judges Scientific plc was established towards the end of 2002, with its re-admission to AIM occurring in May 2005. David Cicurel is recognized as the company's founder and current CEO, holding 11% of the outstanding shares as of May 2022.
Founding and Early Strategy
Judges Scientific plc was formed in late 2002. The company's initial business model underwent a significant shift early in its history.
Pivot to Niche Acquisitions
The company pivoted from a public-to-private arbitrage strategy. It began acquiring and holding quality, private companies that were leaders in niche scientific instrument markets.
Acquisition of Fire Testing Technology
The first acquisition in the scientific instrument sector was Fire Testing Technology. This acquisition took place in May 2005, marking a key moment in the company's strategic direction.
Acquisition Criteria
The strategy focused on acquiring businesses with high operating margins. Valuations were typically between 3-6x EBIT, often financed with around 50% debt.
Focus on UK IP and Exports
A key element of the strategy was acquiring UK intellectual property. The company aimed to drive export sales growth, with over 85% of sales originating from outside the UK by 2017.
Founder's Ownership Stake
David Cicurel, the founder and CEO, maintained a significant ownership stake. As of May 2022, he owned 11% of the company's shares.
Specific details concerning the equity distribution or shareholding percentages of other early investors, such as angel investors or friends and family during the initial formation phase, are not readily available in the provided information. This focus on acquiring niche market leaders aligns with the company's Target Market of Judges Scientific.
Early Ownership Landscape
While David Cicurel remains a significant shareholder, the precise breakdown of early ownership involving other backers is not publicly detailed.
- Founder: David Cicurel
- CEO: David Cicurel
- Founder's Ownership (May 2022): 11%
- Initial Strategy: Public-to-private arbitrage pivot
- First Acquisition: Fire Testing Technology (May 2005)
- Acquisition Focus: Niche scientific instrument companies
Complete Judges Scientific Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has Judges Scientific’s Ownership Changed Over Time?
Judges Scientific plc's ownership structure has evolved significantly since its Initial Public Offering on May 24, 2005. The company's strategic focus on acquiring niche scientific instrument manufacturers has shaped its shareholder base over time, integrating new stakeholders through its 'buy and build' approach.
| Shareholder | Number of Shares | Percentage of Issued Share Capital |
|---|---|---|
| David Cicurel (CEO) | 611,355 | 9.2% |
| Odin Global | 582,426 | 8.8% |
| ODIN Forvaltning AS (as of Sep 2024) | 8.37% | |
| Liontrust | 272,223 | 4.1% |
| Interactive Brokers | 265,200 | 4.0% |
| Broadcrest | 250,380 | 3.8% |
As of July 31, 2025, Judges Scientific plc has a total issued share capital of 6,648,952 ordinary shares. The company's ownership is distributed among its CEO, David Cicurel, who holds 9.2% of the shares, and several significant institutional investors. These include Odin Global with 8.8%, Liontrust at 4.1%, Interactive Brokers holding 4.0%, and Broadcrest with 3.8%. ODIN Forvaltning AS also increased its voting rights to 8.37% as of September 26, 2024. Beyond these major shareholders, other institutional investors such as Hargreaves Lansdown, Capital Group, EFG Harris Allday, Canaccord Genuity, Rathbones, BlackRock, and JP Morgan Asset Management maintain notable stakes. Furthermore, a substantial number of employees have acquired shares through the Judges Scientific Share Incentive Plan, a scheme approved by HMRC that matches employee investments up to £900 annually, reflecting broad employee participation in the company's ownership.
Key Aspects of Judges Scientific Ownership
Understanding the ownership of Judges Scientific plc provides insight into its strategic direction and governance.
- The company employs a 'buy and build' strategy, acquiring smaller scientific instrument manufacturers.
- David Cicurel, the CEO, is a significant individual shareholder.
- Institutional investors collectively hold a substantial portion of the company's shares.
- An employee share incentive plan encourages broad ownership among staff.
- The company's acquisition history, including 25 businesses acquired since its 2005 AIM re-admission, influences its shareholder composition.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on Judges Scientific’s Board?
The Board of Directors of Judges Scientific plc is structured to oversee the company's strategic direction and governance. As of early 2025, the board includes key executive and non-executive members, with recent changes aimed at strengthening leadership and succession planning.
| Director Name | Role | Committee Membership |
|---|---|---|
| David Cicurel | Chief Executive | |
| Brad Ormsby | Chief Financial Officer | |
| Mark Lavelle | Chief Operating Officer (retiring May 2025) | |
| Ralph Elman | Non-Executive Chair (from Jan 1, 2025) | Audit Committee Chair |
| Charles Holroyd | Non-Executive Director | Audit Committee, Remuneration Committee Chair |
| Lushani Kodituwakku | Non-Executive Director | Remuneration Committee |
| Sue Nyman | Non-Executive Director | Audit Committee, Remuneration Committee |
| Tim Prestidge | Group Business Development Director | |
| Ian Wilcock | Group Commercial Director |
Voting power within Judges Scientific plc is distributed based on ordinary share ownership, with each share granting one vote. As of July 31, 2025, there are a total of 6,648,952 Ordinary Shares representing voting rights. While no specific classes of shares with preferential voting rights are noted, significant individual shareholdings, such as that of CEO David Cicurel at 9.2% as of March 2025, can influence voting outcomes. The company adheres to the UK City Code on Takeovers and Mergers, which governs significant ownership changes and potential acquisitions, impacting Judges Scientific ownership structure.
Key Board and Ownership Dynamics
Understanding the board and voting power is crucial for grasping Judges Scientific company ownership. Recent leadership transitions and the distribution of voting rights provide insight into the company's governance and how decisions are made.
- The board composition includes 3 Executive Directors and 5 Non-Executive Directors.
- Ralph Elman assumed the role of Non-Executive Chair on January 1, 2025.
- CEO David Cicurel holds a substantial ownership stake of 9.2% as of March 2025.
- All ordinary shares carry equal voting rights, totaling 6,648,952 as of July 31, 2025.
- The company's operations are guided by principles outlined in its Mission, Vision & Core Values of Judges Scientific.
Judges Scientific Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped Judges Scientific’s Ownership Landscape?
Judges Scientific plc has maintained a consistent strategy focused on acquisitions and enhancing shareholder value over the past three to five years. This approach is evident in its ongoing 'buy and build' activities, alongside efforts to manage debt and distribute dividends.
| Year | Acquisitions Completed | Adjusted Operating Profit | Adjusted Basic EPS | Total Dividend | Cash from Operations |
|---|---|---|---|---|---|
| 2024 | 3 (incl. Teer Coatings for $15.8 million) | £27.9 million (-19.8%) | 283.4p (-24%) | 104.5p (+10%) | £34.0 million |
Leadership transitions are underway, with Hon. Alexander Hambro retiring as Chairman at the close of 2024 and Ralph Elman assuming the Non-Executive Chair role from January 1, 2025. COO Mark Lavelle is slated for retirement by September 2026, with a transition to an Executive Committee role in May 2025. The appointment of Rik Armitage as Group Acquisitions Executive in July 2025 underscores the company's commitment to expanding its acquisition pipeline.
Strategic Acquisitions Drive Growth
In 2024, Judges Scientific plc completed three acquisitions, including Teer Coatings for $15.8 million. This aligns with the company's long-term 'buy and build' strategy.
Shareholder Returns Maintained
Despite a challenging trading year in 2024, the company increased its total dividend by 10% to 104.5p per share. Cash generated from operations remained robust at £34.0 million.
Leadership Evolution
Key leadership changes are occurring, including the retirement of the Chairman and the appointment of a new Non-Executive Chair. These shifts are part of the company's ongoing corporate governance evolution.
Ownership Landscape
Major shareholders as of March 2025 include institutional investors like Odin Global, Liontrust, and BlackRock, alongside CEO David Cicurel. Employee ownership is also fostered through a Share Incentive Plan.
The ownership structure of Judges Scientific plc reflects typical trends for growing public companies, with increasing institutional investor involvement. As of March 2025, significant holdings are with institutional investors such as Odin Global, Liontrust, and BlackRock. CEO David Cicurel also maintains a substantial individual stake. The company's Growth Strategy of Judges Scientific is supported by a banking facility extended and increased to £140 million, including a £50 million accordion, providing capacity for future acquisitions. The company anticipates 2025 performance to align with market expectations, with organic order intake showing slight improvement over early 2024 levels and contributions from deferred projects, though it remains cautious of macroeconomic uncertainties like trade wars and potential disruptions to US research funding.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of Judges Scientific Company?
- What is Competitive Landscape of Judges Scientific Company?
- What is Growth Strategy and Future Prospects of Judges Scientific Company?
- How Does Judges Scientific Company Work?
- What is Sales and Marketing Strategy of Judges Scientific Company?
- What are Mission Vision & Core Values of Judges Scientific Company?
- What is Customer Demographics and Target Market of Judges Scientific Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.